HLX22-GC-301: A Phase III; Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Title
- A Phase III; Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Principal Investigator
- Daboul, Nour
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Gastrointestinal Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Meg Zafiris
- Research Specialist
- Email: margaret.zafiris@hsc.wvu.edu